ReviewJournal of cancer & allied specialties2023

Indoleamine 2,3-Dioxygenase: A Novel Immunotherapeutic Target for Osteosarcoma.

Asim Farooq et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.